Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J De Bree

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Journal of Virus Eradication|June 30, 2022
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
The Journal of General Virology|July 23, 2004
Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopesJojanneke Heidema, Godelieve J de Bree, Patricia M A de Graaff, et al.
The Journal of Infectious Diseases|April 20, 2005
Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly personsGodelieve J de Bree, Jojanneke Heidema, Ester M M van Leeuwen, et al.
AIDS Research and Human Retroviruses|October 4, 2023
Perceptions of Rapid Antiretroviral Therapy Initiation Among Participants of The Netherlands Cohort Study on Acute HIV InfectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
Blood|April 12, 2003
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemiaWendelina J M Mackus, Florine N J Frakking, Annette Grummels, et al.
Vaccines|May 28, 2022
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive TherapyHannah M Garcia Garrido, Albert Vollaard, Geert R D'Haens, et al.
AIDS (London, England)|February 14, 2025
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruptionPien M van Paassen, Anders C Boyd, Alexander O Pasternak, et al.
Plos One|March 16, 2017
Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infectionGodelieve J de Bree, Adam K Wheatley, Rebecca M Lynch, et al.
Elife|August 3, 2022
Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, AmsterdamAlexandra Blenkinsop, Mélodie Monod, Ard van Sighem, et al.
Influenza and Other Respiratory Viruses|October 4, 2023
Two-year trajectories of COVID-19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the NetherlandsElke Wynberg, Anouk Verveen, Hugo D G van Willigen, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Journal of Virus Eradication|June 30, 2022
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
The Journal of General Virology|July 23, 2004
Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopesJojanneke Heidema, Godelieve J de Bree, Patricia M A de Graaff, et al.
The Journal of Infectious Diseases|April 20, 2005
Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly personsGodelieve J de Bree, Jojanneke Heidema, Ester M M van Leeuwen, et al.
AIDS Research and Human Retroviruses|October 4, 2023
Perceptions of Rapid Antiretroviral Therapy Initiation Among Participants of The Netherlands Cohort Study on Acute HIV InfectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
Blood|April 12, 2003
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemiaWendelina J M Mackus, Florine N J Frakking, Annette Grummels, et al.
Vaccines|May 28, 2022
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive TherapyHannah M Garcia Garrido, Albert Vollaard, Geert R D'Haens, et al.
AIDS (London, England)|February 14, 2025
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruptionPien M van Paassen, Anders C Boyd, Alexander O Pasternak, et al.
Plos One|March 16, 2017
Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infectionGodelieve J de Bree, Adam K Wheatley, Rebecca M Lynch, et al.
Elife|August 3, 2022
Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, AmsterdamAlexandra Blenkinsop, Mélodie Monod, Ard van Sighem, et al.
Influenza and Other Respiratory Viruses|October 4, 2023
Two-year trajectories of COVID-19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the NetherlandsElke Wynberg, Anouk Verveen, Hugo D G van Willigen, et al.
Pageof 18